Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Beuers U, Rousseau A, van de Graaf SFJ, Corpechot C

DOI: 10.1097/hc9.0000000000000945
Published: 2026 May 1
Container: Hepatology communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/hc9.0000000000000945,
  title = {Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.},
  author = {Beuers U and Rousseau A and van de Graaf SFJ and Corpechot C},
  year = {2026},
  journal = {Hepatology communications},
  doi = {10.1097/hc9.0000000000000945},
  url = {https://doi.org/10.1097/hc9.0000000000000945}
}

RIS

TY  - JOUR
TI  - Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.
AU  - Beuers U
AU  - Rousseau A
AU  - van de Graaf SFJ
AU  - Corpechot C
PY  - 2026
JO  - Hepatology communications
DO  - 10.1097/hc9.0000000000000945
UR  - https://doi.org/10.1097/hc9.0000000000000945
ER  -

APA

U, B., A, R., SFJ, V. D. G., & C, C. (2026). Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.. Hepatology communications. https://doi.org/10.1097/hc9.0000000000000945

Source records

pubmed · retrieved 2026-09-26T08:05:56.446Z